Shanghai Fosun Pharma Secures GMP Certification & Clinical Trial Launch, Boosting Investor Outlook
Shanghai Fosun Pharmaceutical secures GMP certification and launches Phase IIb trial, boosting pipeline momentum amid sector sell‑off and highlighting strategic growth prospects.
- SHANGHAI FOSUN PHARMACEUTI-A
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read